BioCina

BioCina, founded in 2020, positions itself as an agile CDMO (Contract Development and Manufacturing Organization) partner specializing in both biologics and small molecules. With a commitment encapsulated in its slogan, "Your Agile CDMO Partner for Biologics & Small Molecules," the company provides comprehensive services ranging from cell line development to cGMP manufacturing.

Operating from two modern facilities in Adelaide and Perth, BioCina benefits from regulatory approvals by the Australian TGA, US FDA, EMA, and Health Canada. It boasts a significant global footprint, delivering to 98 countries. Its operations are propelled by skilled industry veterans averaging over a decade in experience.

The company's lack of drug development activities enables its sole focus on advancing client projects. In addition, Australia's attractive R&D tax incentives, offering up to 48.5% cashback, further enhance BioCina's attractiveness as a partner for scaling and manufacturing ventures.